Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply.

Chaisson RE, Ramchandani R, Swindells S.

N Engl J Med. 2019 Sep 12;381(11):e23. doi: 10.1056/NEJMc1908492. No abstract available.

PMID:
31509690
2.

Applying Risk-Benefit Analysis to Outcomes in TB Clinical Trials.

Miyahara S, Ramchandani R, Kim S, Evans SR, Gupta A, Swindells S, Chaisson RE, Montepiedra G.

Clin Infect Dis. 2019 Aug 15. pii: ciz784. doi: 10.1093/cid/ciz784. [Epub ahead of print]

PMID:
31414121
3.

Changing the narrative: responsibility for youth engagement is a two-way street.

Lal A, Bulc B, Bewa MJ, Cassim MY, Choonara S, Efendioglu E, Germann S, Hafeez H, Iversen K, Nishtar S, O'Leary C, Orlic P, Ralston J, Ramchandani R, Walji S.

Lancet Child Adolesc Health. 2019 Oct;3(10):673-675. doi: 10.1016/S2352-4642(19)30247-0. Epub 2019 Aug 9. No abstract available.

PMID:
31405771
4.

Urgency for transformation: youth engagement in global health.

Bulc B, Al-Wahdani B, Bustreo F, Choonara S, Demaio A, Jácome DI, Lal A, Odede JP, Orlic P, Ramchandani R, Walji S.

Lancet Glob Health. 2019 Jul;7(7):e839-e840. doi: 10.1016/S2214-109X(19)30221-9. Epub 2019 May 16. No abstract available.

5.

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.

Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, Jean Juste MA, Lama JR, Valencia J, Omoz-Oarhe A, Supparatpinyo K, Masheto G, Mohapi L, da Silva Escada RO, Mawlana S, Banda P, Severe P, Hakim J, Kanyama C, Langat D, Moran L, Andersen J, Fletcher CV, Nuermberger E, Chaisson RE; BRIEF TB/A5279 Study Team.

N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808.

6.

Are rare cancer survivors at elevated risk of subsequent new cancers?

Finkelstein DM, Horick NK, Ramchandani R, Boyd KL, Rana HQ, Bychkovsky BL.

BMC Cancer. 2019 Feb 21;19(1):166. doi: 10.1186/s12885-019-5358-1.

7.

Estimation for an accelerated failure time model with intermediate states as auxiliary information.

Ramchandani R, Finkelstein DM, Schoenfeld DA.

Lifetime Data Anal. 2018 Nov 1. doi: 10.1007/s10985-018-9452-5. [Epub ahead of print]

PMID:
30386969
8.

Familial Occurrence of Thyroglossal Duct Cyst.

Ramchandani R, Chumber S.

Indian J Surg. 2017 Dec;79(6):566-568. doi: 10.1007/s12262-017-1648-5. Epub 2017 May 25.

9.

Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.

Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, Matoga M, Ngongondo M, Samaneka W, Koech L, Naidoo K, Rassool M, Kirui F, Banda P, Mave V, Kadam D, Leger P, Henestroza G, Manabe YC, Bao J, Kumwenda J, Gupta A, Hosseinipour MC; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

AIDS. 2017 Oct 23;31(16):2217-2225. doi: 10.1097/QAD.0000000000001606.

10.

Incidental intraoperative diagnosis of retained foreign body lung misdiagnosed as pulmonary tuberculosis.

Ramchandani R, Dewan RK, Ramchandani S.

Lung India. 2016 Jul-Aug;33(4):444-6. doi: 10.4103/0970-2113.184926.

11.

Global rank tests for multiple, possibly censored, outcomes.

Ramchandani R, Schoenfeld DA, Finkelstein DM.

Biometrics. 2016 Sep;72(3):926-35. doi: 10.1111/biom.12475. Epub 2016 Jan 26.

12.

Should we welcome multinational companies' involvement in programmes to improve child health?

Berry S, Berry J, Ramchandani R, Spencer N.

BMJ. 2015 Jun 17;350:h3046. doi: 10.1136/bmj.h3046. No abstract available.

PMID:
26085507
13.

A model-informed rank test for right-censored data with intermediate states.

Ramchandani R, Finkelstein DM, Schoenfeld DA.

Stat Med. 2015 Apr 30;34(9):1454-66. doi: 10.1002/sim.6417. Epub 2015 Jan 13.

14.

Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.

Strasser-Weippl K, Ramchandani R, Fan L, Li J, Hurlbert M, Finkelstein D, Shao ZM, Goss PE.

Breast Cancer Res Treat. 2015 Jan;149(1):255-61. doi: 10.1007/s10549-014-3219-9. Epub 2014 Dec 14.

15.
16.

Congenital malformation of lung parenchyma: 15 years experience in a thoracic surgical unit.

Dewan RK, Kesieme EB, Sisodia A, Ramchandani R, Kesieme CN.

Indian J Chest Dis Allied Sci. 2012 Apr-Jun;54(2):105-9.

PMID:
22973779
17.

Feasibility and safety of ultrasound-guided nerve block for management of limb injuries by emergency care physicians.

Bhoi S, Sinha TP, Rodha M, Bhasin A, Ramchandani R, Galwankar S.

J Emerg Trauma Shock. 2012 Jan;5(1):28-32. doi: 10.4103/0974-2700.93107.

18.

Surgical treatment for tracheobronchial carcinoid tumors: a 16-year experience.

Dewan RK, Kesieme EB, Ramchandani R.

Asian Cardiovasc Thorac Ann. 2012 Feb;20(1):53-7. doi: 10.1177/0218492311433775.

PMID:
22371943
19.

Diagnostic accuracy of bedside emergency ultrasound screening for fractures in pediatric trauma patients.

Sinha TP, Bhoi S, Kumar S, Ramchandani R, Goswami A, Kurrey L, Galwankar S.

J Emerg Trauma Shock. 2011 Oct;4(4):443-5. doi: 10.4103/0974-2700.86625.

20.

Socioeconomic status and survival after an invasive breast cancer diagnosis.

Sprague BL, Trentham-Dietz A, Gangnon RE, Ramchandani R, Hampton JM, Robert SA, Remington PL, Newcomb PA.

Cancer. 2011 Apr 1;117(7):1542-51. doi: 10.1002/cncr.25589. Epub 2010 Nov 8.

21.

Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development.

Wang Y, Sung C, Dartois C, Ramchandani R, Booth BP, Rock E, Gobburu J.

Clin Pharmacol Ther. 2009 Aug;86(2):167-74. doi: 10.1038/clpt.2009.64. Epub 2009 May 13.

PMID:
19440187
22.

Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.

Hazarika M, Jiang X, Liu Q, Lee SL, Ramchandani R, Garnett C, Orr MS, Sridhara R, Booth B, Leighton JK, Timmer W, Harapanhalli R, Dagher R, Justice R, Pazdur R.

Clin Cancer Res. 2008 Sep 1;14(17):5325-31. doi: 10.1158/1078-0432.CCR-08-0308.

23.

Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.

Brave M, Goodman V, Kaminskas E, Farrell A, Timmer W, Pope S, Harapanhalli R, Saber H, Morse D, Bullock J, Men A, Noory C, Ramchandani R, Kenna L, Booth B, Gobburu J, Jiang X, Sridhara R, Justice R, Pazdur R.

Clin Cancer Res. 2008 Jan 15;14(2):352-9. doi: 10.1158/1078-0432.CCR-07-4175.

24.

Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.

Goodman VL, Rock EP, Dagher R, Ramchandani RP, Abraham S, Gobburu JV, Booth BP, Verbois SL, Morse DE, Liang CY, Chidambaram N, Jiang JX, Tang S, Mahjoob K, Justice R, Pazdur R.

Clin Cancer Res. 2007 Mar 1;13(5):1367-73. Review.

25.

Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.

Bhattaram VA, Bonapace C, Chilukuri DM, Duan JZ, Garnett C, Gobburu JV, Jang SH, Kenna L, Lesko LJ, Madabushi R, Men Y, Powell JR, Qiu W, Ramchandani RP, Tornoe CW, Wang Y, Zheng JJ.

Clin Pharmacol Ther. 2007 Feb;81(2):213-21.

PMID:
17259946
26.

The role of SN-38 exposure, UGT1A1*28 polymorphism, and baseline bilirubin level in predicting severe irinotecan toxicity.

Ramchandani RP, Wang Y, Booth BP, Ibrahim A, Johnson JR, Rahman A, Mehta M, Innocenti F, Ratain MJ, Gobburu JV.

J Clin Pharmacol. 2007 Jan;47(1):78-86.

PMID:
17192505
27.

Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.

Brave M, Dagher R, Farrell A, Abraham S, Ramchandani R, Gobburu J, Booth B, Jiang X, Sridhara R, Justice R, Pazdur R.

Oncology (Williston Park). 2006 Oct;20(11):1401-4, 1410; discussion 1410-11, 1415-6.

28.

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications.

Bhattaram VA, Booth BP, Ramchandani RP, Beasley BN, Wang Y, Tandon V, Duan JZ, Baweja RK, Marroum PJ, Uppoor RS, Rahman NA, Sahajwalla CG, Powell JR, Mehta MU, Gobburu JV.

AAPS J. 2005 Oct 7;7(3):E503-12. Review.

29.

Respiratory system responsiveness in rabbits in vivo is reduced by prolonged continuous positive airway pressure.

Xue Z, Zhang L, Ramchandani R, Liu Y, Antony VB, Gunst SJ, Tepper RS.

J Appl Physiol (1985). 2005 Aug;99(2):677-82. Epub 2005 Apr 7.

30.

Chronic strain alters the passive and contractile properties of rabbit airways.

Tepper RS, Ramchandani R, Argay E, Zhang L, Xue Z, Liu Y, Gunst SJ.

J Appl Physiol (1985). 2005 May;98(5):1949-54. Epub 2005 Jan 27.

31.

Comparison of elastic properties and contractile responses of isolated airway segments from mature and immature rabbits.

Ramchandani R, Shen X, Gunst SJ, Tepper RS.

J Appl Physiol (1985). 2003 Jul;95(1):265-71.

32.

Computational model of airway narrowing: mature vs. immature rabbit.

Lambert RK, Ramchandani R, Shen X, Gunst SJ, Tepper RS.

J Appl Physiol (1985). 2002 Aug;93(2):611-9.

33.

Bronchoprotective and bronchodilatory effects of deep inspiration in rabbits subjected to bronchial challenge.

Gunst SJ, Shen X, Ramchandani R, Tepper RS.

J Appl Physiol (1985). 2001 Dec;91(6):2511-6.

34.

Airway branching morphology of mature and immature rabbit lungs.

Ramchandani R, Bates JH, Shen X, Suki B, Tepper RS.

J Appl Physiol (1985). 2001 Apr;90(4):1584-92.

35.

Effect of transpulmonary pressure on airway diameter and responsiveness of immature and mature rabbits.

Shen X, Ramchandani R, Dunn B, Lambert R, Gunst SJ, Tepper RS.

J Appl Physiol (1985). 2000 Oct;89(4):1584-90.

36.

Differences in airway structure in immature and mature rabbits.

Ramchandani R, Shen X, Elmsley CL, Ambrosius WT, Gunst SJ, Tepper RS.

J Appl Physiol (1985). 2000 Oct;89(4):1310-6.

37.

Comparative respiratory system mechanics in rodents.

Gomes RF, Shen X, Ramchandani R, Tepper RS, Bates JH.

J Appl Physiol (1985). 2000 Sep;89(3):908-16.

Supplemental Content

Loading ...
Support Center